ANXA2 and pancreatic ductal adenocarcinoma: Moreover, anti-annexin A2 antibodies have been shown to inhibit pancreatic cancer metastasis in a mouse model of pancreatic ductal adenocarcinoma [10] and to inhibit tumor growth in breast cancer and Lewis Lung Carcinoma xenograft mouse models [32, 33].